Loading clinical trials...
Loading clinical trials...
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Multicenter, Parallel Group Study to Evaluate the Safety and Analgesic Activity of ATx08-001 When Administered to Subjects With Postherpetic Neuralgia
Conditions
Interventions
ATx08-001
Placebo
Locations
9
United States
Radiant Research
Chandler, Arizona, United States
Premier Research Center
Peoria, Arizona, United States
Homestead Clinical Research
Cutler Bay (Miami), Florida, United States
San Marcus Research Clinic
Miami, Florida, United States
Boston Clinical Trials
Boston, Massachusetts, United States
Quest Research Institute
Bingham Farms, Michigan, United States
Start Date
March 1, 2011
Primary Completion Date
July 1, 2011
Completion Date
July 1, 2011
Last Updated
August 23, 2011
NCT07000409
NCT06896994
NCT06232486
NCT06225960
NCT07367152
NCT01106716
Lead Sponsor
Aestus Therapeutics
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions